Rahmana Emran Kartasasmita
Bandung Institute of Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rahmana Emran Kartasasmita.
Journal of Biomolecular Structure & Dynamics | 2016
Muhammad Arba; Rahmana Emran Kartasasmita; Daryono H. Tjahjono
A series of cationic porphyrin–anthraquinone hybrids bearing either pyridine, imidazole, or pyrazole rings at the meso-positions have been investigated for their interaction with DNA G-quadruplexes by employing molecular docking and molecular dynamics simulations. Three types of DNA G-quadruplexes were utilized, which comprise parallel, antiparallel, and mixed hybrid topologies. The porphyrin hybrids have a preference to bind with parallel and mixed hybrid structures compared to the antiparallel structure. This preference arises from the end stacking of porphyrin moiety following G-stem and loop binding of anthraquinone tail, which is not found in the antiparallel due to the presence of diagonal and lateral loops that crowd the G-quartet. The binding to the antiparallel, instead, occurred with poorer affinity through both the loop and wide groove. All sites of porphyrin binding were confirmed by 6 ns molecular dynamics simulation, as well as by the negative value of the total binding free energies that were calculated using the MMPBSA method. Free energy analysis shows that the favorable contribution came from the electrostatic term, which supposedly originated from the interaction of either cationic pyridinium, pyrazole, or imidazole groups and the anionic phosphate backbone, and also from the van der Waals energy, which primarily contributed through end stacking interaction.
Pharmaceuticals | 2018
Fransiska Kurniawan; Youhei Miura; Rahmana Emran Kartasasmita; Naoki Yoshioka; Abdul Mutalib; Daryono H. Tjahjono
Five known porphyrins, 5,10,15,20-tetrakis(p-tolyl)porphyrin (TTP), 5,10,15,20-tetrakis(p-bromophenyl)porphyrin (TBrPP), 5,10,15,20-tetrakis(p-aminophenyl)porphyrin (TAPP), 5,10,15-tris(tolyl)-20-mono(p-nitrophenyl)porphyrin (TrTMNP), 5,10,15-tris(tolyl)-20-mono(p-aminophenyl)porphyrin (TrTMAP), and three novel porphyrin derivatives, 5,15-di-[bis(3,4-ethylcarboxymethylenoxy)phenyl]-10,20-di(p-tolyl)porphyrin (DBECPDTP), 5,10-di-[bis(3,4-ethylcarboxymethylenoxy)phenyl]-15,20-di-(methylpyrazole-4-yl)porphyrin (cDBECPDPzP), 5,15-di-[bis(3,4-ethylcarboxymethylenoxy)phenyl]-10,20-di-(methylpyrazole-4-yl)porphyrin (DBECPDPzP), were used to study their interaction with protein targets (in silico study), and were synthesized. Their cytotoxic activities against cancer cell lines were tested using 3-(4,5-dimetiltiazol-2-il)-2,5-difeniltetrazolium bromide (MTT) assay. The interaction of porphyrin derivatives with carbonic anhydrase IX (CAIX) and REV-ERBβ proteins were studied by molecular docking and molecular dynamic simulation. In silico study results reveal that DBECPDPzP and TrTMNP showed the highest binding interaction with REV- ERBβ and CAIX, respectively, and both complexes of DBECPDPzP-REV-ERBβ and TrTMNP-CAIX showed good and comparable stability during molecular dynamic simulation. The studied porphyrins have selective growth inhibition activities against tested cancer cells and are categorized as marginally active compounds based on their IC50.
Current Computer - Aided Drug Design | 2018
Fransiska Kurniawan; Rahmana Emran Kartasasmita; Naoki Yoshioka; Abdul Mutalib; Daryono H. Tjahjono
BACKGROUND Melanoma is the most aggressive type of skin cancer. Metastatic melanoma is extremely difficult to treat with current therapy methods such as surgery. On the other hand, it is a good opportunity to develop a radiopharmaceutical using a radionuclide such as Technetium (Tc) for diagnostic and Rhenium (Re) for therapeutic purposes. T3,4BCPP has been be used as a radioimaging agent for melanoma cancers experimentally. The aim of the present research was to design new imidazolylporphyrin derivatives with better selectivity and higher affinity than those of T3,4BCPP by molecular modeling. METHODS Eight types of Re- and Tc-labeled imidazolylporphyrins were docked to Fibroblast Growth Factor Receptor 1 (FGFR1, PDB ID: 5AM6) using AutoDock 4.2. FGFR1 was simulated by Molecular Dynamic (MD) simulation for 30 ns using NAMD 2.10 at 37 °C. The obtained conformations were then applied in a molecular docking simulation. Dovitinib (natural ligand of FGFR1), Re- and Tc-T3, 4BCPP were used as references. RESULTS The MD simulation resulted in an RMSD of 3.8 Å. From all the studied imidazolylporphyrin derivatives, Tc-cD3, 4BCPMIP and Re-cD3, 4BCPIP had the best docking parameter. Tc-cD3, 4BCPMIP had a free binding energy of -4.06 kcal/mol, while that of Re-cD3, 4BCPIP was -4.35 kcal/mol. CONCLUSION It is concluded that cD3,4BCPMIP and cD3,4BCPIP are two potential candidate ligands for a melanoma radiopharmaceutical kit.
Archive | 2013
Ida Musfiroh; Yasmiwar Susilawati; Muchtaridi Muchtaridi; Resmi Mustarichie; Ahmad Muhtadi; Rahmana Emran Kartasasmita; Ajeng Diantini; Slamet Ibrahim; Aliya Nur Hasanah; Linar Zalinar Udin
Journal of Biological Inorganic Chemistry | 2006
Daryono H. Tjahjono; Rahmana Emran Kartasasmita; As’ari Nawawi; Shunsuke Mima; Takehiro Akutsu; Naoki Yoshioka; Hidenari Inoue
Journal of Materials Chemistry B | 2015
A. N. Hasanah; Federica Pessagno; Rahmana Emran Kartasasmita; Slamet Ibrahim; Panagiotis Manesiotis
Journal of Mathematical and Fundamental Sciences | 2016
Rina Herowati; Rahmana Emran Kartasasmita; I Ketut Adnyana; Tutus Gusdinar Kartawinata
Kartika Jurnal Ilmiah Farmasi | 2017
Mira Andam Dewi; Rahmana Emran Kartasasmita; Marlia Singgih Wibowo
2nd ISEJ 2017 Abstract and Full Paper Submission System | 2017
Mira Andam Dewi; Rahmana Emran Kartasasmita; Marlia Singgih Wibowo
international journal of chemical sciences | 2015
Ida Musfiroh; W. Sri Rizky; Winasih; Ahmad Muhtadi; Rahmana Emran Kartasasmita; Slamet Ibrahim